8.6K views · 260 reactions | Acute GVHD is a major complication and cause of death after allogeneic hematopoietic stem-cell transplantation. Even with standard prophylaxis regimens, GVHD occurs in 34 to 51% of patients within 100 days of transplantation. New research findings are summarized in a short video. To read the full article, click the link: https://nej.md/3baWUWd | The New England Journal of Medicine | Facebook

Learn more about Haplo Identical Stem Cell Transplantation as Dr. Francis Lopez, our Head of Bone Marrow Transplant Unit, talks about its benefits and advantages for our patients with blood disorders. | St. Luke's Medical Center